DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Bydureon (Exenatide) - Injection Site Haemorrhage - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Injection Site Haemorrhage (13)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Bydureon (Exenatide) where reactions include injection site haemorrhage. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Bydureon side effects in male

Reported by a consumer/non-health professional from Germany on 2012-08-14

Patient: male

Reactions: Glycosylated Haemoglobin Increased, Injection Site Inflammation, Injection Site Haemorrhage, Injection Site Abscess, Injection Site Pain, Injection Site Nodule

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bydureon

Other drugs received by patient: Loratadine; Atacand; Metformin HCL



Possible Bydureon side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-05

Patient: male, weighing 85.3 kg (187.6 pounds)

Reactions: Cardiac Flutter, Nausea, Injection Site Haemorrhage, Intentional Drug Misuse, Blood Glucose Decreased, Fatigue, Dizziness, Blood Creatinine Increased, Injection Site Nodule, Blood Glucose Increased, Influenza

Drug(s) suspected as cause:
Byetta
    Dosage: 5 ug, bid
    Indication: Type 2 Diabetes Mellitus
    Start date: 2005-01-01

Byetta
    Dosage: 10 ug, bid
    Start date: 2012-06-11

Bydureon
    Dosage: 2 mg, weekly (1/w)
    Indication: Type 2 Diabetes Mellitus
    Start date: 2012-05-15
    End date: 2012-06-03

Byetta
    Dosage: 10 ug, bid
    End date: 2012-05-14

Other drugs received by patient: Zetia; Aspirin / USA /; Metoprolol Succinate; Multi-Vitamin; Carvedilol; Glucophage / USA /; Glipizide; Lipitor; Diovan; Glucophage / USA /; Trilipix; Diovan; Folic Acid; Prevacid; Vitamin B6; Flomax; Vitamin B-12



Possible Bydureon side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-27

Patient: male, weighing 83.9 kg (184.6 pounds)

Reactions: Cardiac Flutter, Injection Site Haemorrhage, Nausea, Intentional Drug Misuse, Blood Glucose Decreased, Fatigue, Dizziness, Blood Creatinine Increased, Blood Glucose Increased, Influenza

Drug(s) suspected as cause:
Bydureon
    Dosage: 2 mg, weekly (1/w)
    Indication: Type 2 Diabetes Mellitus
    Start date: 2012-05-13
    End date: 2012-06-03

Byetta
    Dosage: 5 ug, bid
    Indication: Type 2 Diabetes Mellitus
    Start date: 2005-01-01

Byetta
    Dosage: 10 ug, bid
    End date: 2012-05-14

Byetta
    Dosage: 5 ug, bid
    Start date: 2012-06-11

Other drugs received by patient: Diovan; Folic Acid; Metoprolol Tartrate; Glucophage / USA /; Glipizide; Glucophage / USA /; Trilipix; Zetia; Lipitor; Carvedilol; Prevacid; Aspirin / USA /; Vitamin B-12; Multi-Vitamin; Flomax; Vitamin B6



Possible Bydureon side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-18

Patient: male, weighing 83.9 kg (184.6 pounds)

Reactions: Cardiac Flutter, Nausea, Injection Site Haemorrhage, Intentional Drug Misuse, Blood Glucose Decreased, Fatigue, Dizziness, Blood Creatinine Increased, Blood Glucose Increased, Influenza

Drug(s) suspected as cause:
Byetta
    Dosage: 10 ug, bid
    End date: 2012-05-14

Byetta
    Dosage: 5 ug, bid
    Indication: Type 2 Diabetes Mellitus
    Start date: 2005-01-01

Bydureon
    Dosage: 2 mg, weekly (1/w)
    Indication: Type 2 Diabetes Mellitus
    Start date: 2012-05-13
    End date: 2012-06-03

Byetta
    Dosage: 10 ug, bid
    Start date: 2012-06-11

Other drugs received by patient: Glipizide; Glucophage / USA /



Possible Bydureon side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-18

Patient: male, weighing 104.3 kg (229.5 pounds)

Reactions: Injection Site Haemorrhage, Muscular Weakness, Atrial Fibrillation, Underdose, Blood Magnesium Decreased, Dizziness, Atrioventricular Block, Gait Disturbance, Depression, Cardiac Arrest

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Bydureon
    Dosage: 2 mg, weekly (1/w)
    Indication: Type 2 Diabetes Mellitus
    Start date: 2012-03-31

Byetta
    Dosage: 10 ug, bid
    Indication: Type 2 Diabetes Mellitus
    Start date: 2005-01-01
    End date: 2012-03-01

Other drugs received by patient: Metformin; Aspirin / USA /; Lexapro; Lipitor; Metformin; Xalatan; Carvedilol; Diovan; Oxybutynin; Zetia; Prilosec



Possible Bydureon side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-07

Patient: female, weighing 138.8 kg (305.3 pounds)

Reactions: Weight Decreased, Abdominal Pain, Back Pain, Gallbladder Enlargement, Injection Site Haemorrhage, Urinary Tract Infection, Pain, Cholelithiasis, Glycosylated Haemoglobin Increased, Pancreatitis, Gallbladder Polyp, Blood Glucose Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Byetta
    Dosage: 5 ug, bid
    Indication: Type 2 Diabetes Mellitus
    Start date: 2007-01-01

Byetta
    Dosage: 10 ug, bid
    End date: 2012-05-01

Bydureon
    Dosage: 2 mg, weekly (1/w)
    End date: 2012-05-16

Bydureon
    Dosage: 2 mg, weekly (1/w)
    Indication: Type 2 Diabetes Mellitus
    Start date: 2012-05-02

Bydureon
    Dosage: 2 mg, weekly (1/w)

Other drugs received by patient: Klor-CON; Nexium; Calcium; Benicar; Meloxicam; Metoprolol; Vitamin TAB; Ramipril; Glimepiride; Atorvastatin Calcium; Hydrochlorothiazde TAB; Bupropion HCL; Gabapentin



Possible Bydureon side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-06

Patient: male, weighing 83.9 kg (184.6 pounds)

Reactions: Blood Glucose Decreased, Cardiac Flutter, Fatigue, Injection Site Haemorrhage, Nausea, Dizziness, Blood Glucose Increased, Influenza

Drug(s) suspected as cause:
Byetta
    Dosage: 10 ug, bid
    End date: 2012-05-14

Byetta
    Dosage: 5 ug, bid
    Indication: Type 2 Diabetes Mellitus
    Start date: 2005-01-01

Bydureon
    Dosage: 2 mg, weekly (1/w)
    Indication: Type 2 Diabetes Mellitus
    Start date: 2012-05-15

Other drugs received by patient: Glucophage / USA /; Glipizide



Possible Bydureon side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-23

Patient: female

Reactions: Gallbladder Enlargement, Cholelithiasis, Abdominal Pain, Glycosylated Haemoglobin Increased, Injection Site Haemorrhage, Gallbladder Polyp, Blood Glucose Increased

Drug(s) suspected as cause:
Byetta
    Dosage: 5 ug, bid
    Indication: Type 2 Diabetes Mellitus
    Start date: 2007-01-01

Bydureon
    Dosage: 2 mg, weekly (1/w)

Bydureon
    Dosage: 2 mg, weekly (1/w)
    Indication: Type 2 Diabetes Mellitus
    Start date: 2012-05-02

Byetta
    Dosage: 10 ug, bid
    End date: 2012-05-01

Other drugs received by patient: Nexium; Ramipril; Benicar; Klor-CON; Atorvastatin Calcium; Gabapentin; Meloxicam; Glimepiride; Hydrochlorothiazide; Bupropion HCL



Possible Bydureon side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-23

Patient: female, weighing 59.0 kg (129.7 pounds)

Reactions: Blood Urine Present, Injection Site Haemorrhage, Haemorrhage, Injection Site Pain, Off Label Use, Dysuria, Blood Glucose Increased, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bydureon

Other drugs received by patient: Insulin; Novolog; Kombiglyze XR



Possible Bydureon side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-18

Patient: female

Reactions: Blood Pressure Increased, Weight Decreased, Cellulitis, Injection Site Haemorrhage, Intentional Drug Misuse, Panic Disorder, Cardiac Disorder, Chest Pain, Blood Glucose Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Byetta
    Dosage: 10 ug, bid
    Indication: Type 2 Diabetes Mellitus

Bydureon
    Dosage: 2 mg, weekly (1/w)
    Indication: Type 2 Diabetes Mellitus
    Start date: 2012-03-01

Other drugs received by patient: Metformin HCL; Beta Blocking Agents



Possible Bydureon side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-14

Patient: female

Reactions: Injection Site Haemorrhage, Injection Site Nodule

Drug(s) suspected as cause:
Bydureon



Possible Bydureon side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-03

Patient: male, weighing 139.7 kg (307.3 pounds)

Reactions: Weight Decreased, Nasopharyngitis, Injection Site Haemorrhage, Pain, Loss of Consciousness, Road Traffic Accident, Injection Site Erythema, Injection Site Induration, Hearing Impaired, Cough, Oxygen Saturation Decreased, Decreased Appetite, Injection Site Mass, Injection Site Pain, Nasal Congestion, Injection Site Pruritus, Dysphonia, Presyncope, Bronchitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bydureon
    Dosage: 2 mg, weekly (1/w)

Bydureon
    Dosage: 2 mg, weekly (1/w)
    Indication: Type 2 Diabetes Mellitus
    Start date: 2012-03-12

Other drugs received by patient: Januvia



Possible Bydureon side effects in male

Reported by a consumer/non-health professional from Ireland on 2012-02-15

Patient: male

Reactions: Dysgeusia, Off Label Use, Injection Site Haemorrhage, Laceration, Cerebrovascular Accident, Incorrect Storage of Drug, Venous Injury

Drug(s) suspected as cause:
Bydureon

Other drugs received by patient: Lantus; Lantus; Novorapid; Caprin; Novorapid

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017